chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At approx 11:25 (2/19/2022), pt received booster dose of covid vaccine(Pfizer), pt reported feeling "very tense". Approx 10 min after administration, pt became pale, while sitting in chair next to RN, then she appeared to pass out,vitals taken, appear to be wnl within 1 minute, pt became responsive, although epi pen was available, (pt with allergy to seafood, peanuts), pt did not show s/s shortness of breath, parents declined giving epi also. Pt oriented, mother of pt reported that pt has passed out with a blood draw, with spontaneous recovery immediately, pt denied shortness of breath, pain, headache,pt remained laying down for aprox 5 min, sat up without s/s,reports she didnt eat this afternoon, so she drank juice, denies hunger at this time. Pt  transferred to wheelchair then , to observation for 30 min, with parents, vs taken when she arrived into observation, and prior to pt leaving clinic. Parents report that they will watch her, but they felt this episode was r/t vagal response.\
Patient received her 2nd dose of the Moderna COVID-19 vaccine on 2/26/2021 at approximately 01:30 PM. Patient came into my office on 03/02/2021 with a complaint of elevated blood pressures over the weekend- in the 150-160/90-100 range, shortness of breath on exertion and light-headedness, fatigue, and tachycardia since Sunday evening (2/28/2021). Patient's blood pressure in the office was 174/100 and her heart rate was running 90's-100 at rest. Patient was still feeling short of breath if she was up moving. Patient's blood pressure came down to 162/94 in the office and her heart rate came down to 92 after sitting in the office for about 15 minutes. Patient reported that she has a medical history including hypertension and mitral valve prolapse but she had never been on medication for MVP and never had problems with high heart rate until now- reports that it usually runs in the 70-80 range. Patient reports that previous to vaccination her blood pressure had been running in the normal range 120's/70's the majority of the time on lisinopril-hydrochlorothiazide 20-25 mg daily alone. Patient was started on Metoprolol ER 25 mg daily for better blood pressure and heart rate control and I plan to follow up with her in office next week and patient is to continue monitoring her heart rate and blood pressure at home.
Patient reports feeling dizzy, exhibited flushing, sweating, and lightheadedness. Had wheezing for 1-2 minutes. Has history of anxiety for needles.  Cleared by EMS and refused ER transport. BP - 92/52
Pt recv vax on 10/19/98; on same day pt exp arm ache, fatigue, bone aches, dizzy; pt imp 30 hr
Pharmacist did not ask me to take off my shirt. I had a long sleeve shirt. Instead she had me roll up my sleeves only. My sleeves did not roll up to the shoulder. My sleeves were covering my Deltoid area where the jab should have been done. She jabbed me below Deltoid muscle. Because she jabbed me in tendon area or area below the Deltoid, I am now suffering from severe arm and shoulder pain. I am 2 500mg doses of ETODOLAC per day. My Dr. recommended physical therapy. So I am in physical therapy 3 days a week. My Dr. also wants my arm and shoulder in gel ice pack which I am doing every day. As of 9/15/21, the pain still persists and it makes it hard for me to function.
A health professional report has been received. The report concerns 4 year old, Female consumer, who had been receiving Nasal FLUMIST Quadrivalent (Intranasal), 0.2 milliliters, Unknown for Influenza. FLUMIST Quadrivalent (Intranasal) started on 15-JAN-2016 for Influenza. Reporter stated that FLUMIST that expired on January13, 2016 was administered today to a 4 year girl. FLUMIST Quadrivalent (Intranasal) was continued. The outcome of the event of administered an expired drug is unknown. The report was considered to be non-serious.
All over body aches (especially left arm near injection site) headache and dizziness through out the day on 2/6/21.  Around 11:10 pm on 2/6/21, I noticed my left bicep was swollen,  after checking not only was it swollen, it was very hard to the touch as well as a red circle around the injection site.
Callers dad had a fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose number unknown, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The caller's dad had a fever for the past day and a half after getting vaccine on an unspecified date. The outcome of the event was unknown.    No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
Information has been received from a medical assistant referring to multiple unspecified patients. The patients' concurrent condition, medical history and concomitant medication were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose and route were unknown, lot # L018501, expiration date 22-JUN-2017; lot # L027733, expiration date 13-SEP-2017). No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
UNABLE TO MOVE OUT OF BED; VERY WEAK; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a 42 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included food allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 14:00 on right arm for prophylactic vaccination. No concomitant medications were reported.  On 01-APR-2021, the subject experienced unable to move out of bed. On 01-APR-2021, the subject experienced very weak. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, unable to move out of bed, and very weak. This report was non-serious.
Information has been received from a physician concerning a 19 year old female who on 25-Jun-2007 was vaccinated with her first dose of Gardasil (lot # as reported "5234U").  On 16-Aug-2007 the patient was vaccinated with her second dose of Gardasil (lot # as reported "802UU").  On approximately 06-Sep-2007 the patient experienced conjuctival squamous papilloma.  Subsequently, the patient recovered from conjuctival squamous papilloma.  Additional information has been requested.
A non-serious spontaneous report of "patient jerked and went into eye and eye somewhat red" has been received from a consumer concerning a 24-month-old male, subsequent to H1N1. The patient's past medical history and concomitant medications were not reported. The patient who is the reporter's son received H1N1 on 22-Oct-2009 at a large flu clinic. During vaccination, the first spray did not all go up the patient's nose. He jerked and some went into his eye. On 23-Oct-2009, the patient's eye was somewhat red. The outcome of the adverse events is unknown.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns an 87-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6-degree Celsius. On 19-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250802, expiry date: 30-Jun-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805439 was crossed linked to original cases 201804863 due to same reporter.
No adverse event; First dose administered on 19Aug2020 and second dose on 12Oct2020; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 19Aug2020 and second dose on 12Oct2020) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Aug-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Oct-2020, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 19Aug2020 and second dose on 12Oct2020). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 19Aug2020 and second dose on 12Oct2020) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant drug information was provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment drug information was reported.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medications were not reported.  Reporter stated that no adverse reactions were reported by any patients.
FOLLOWING SECOND DOSE OF COVID-19 VACCINE PATIENT REPORTED TINGLING OF LIPS ON THE LEFT SIDE. PATIENT WAS TAKEN TO MEDICS FOR FURTHER OBSERVATION. PATIENT WAS GIVEN 25MG OF BENADRYL PO FROM HHS MEDIC. PATIENT RECOVERED AND THAN LEFT THE PREMISES.
Rapid heartbeat of 135 bpm Blood pressure 176/110  No treatment  Symptoms resolved themselves after 1 hour
localized delayed hypersensitivity reactions- swelling, tender, redness, warm to touch
Within 1 hour after vaccine administration, eyes started swelling, eyes watery and whelps on throat.  Resolved by 11/11/12.  Administered Benadryl Liquid 2 doses 1 hour apart.
Pt was vaccinated with the Moderna series on June 24, 2022 and July 22, 2022.  Pt did have 1 day of fevers after his dose 2. Shortly after his second dose, around August, pt periodically would mention that his right hip hurt. (pointing to his right inguinal area).  He did not have any change in gait and symptoms seemed transient so no medical care was sought. Pt continued to have similar short lived complaints during the month, probably at max 1-2x a week.  Also during the month of August he may have had 1-2 mild colds with solely rhinnorea.    On Sept 9, 2022, pt developed worsening right hip pain that did not resolve.  He also developed a limp. Within 24 hours he was not able to ambulate and had significant pain on movement. ER visit ruled out septic hip, avascular neceosis, but ultrasound did show significant effusion in the right hip with some mild effusion on the left hip.  A diagnosis of transient synovisitis was made. However, history was perplexing because he had intermittent symptoms for a whole month prior with a sudden acute worsening. It is believed that the moderna vaccine dose 2 caused an inflammatory response that caused some mild effusions that resulted in intermittnet pain in August. Then his mild URIs caused an acute worsening that lead to the transient synovitis.
This spontaneous report as received from a registered nurse refers to a 2 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-APR-2017, the patient was vaccinated with the improperly stored (between 6 and 14 degrees Fahrenheit for 30 minutes) dose of VARIVAX (for prophylaxis, lot # L050561 with expiration date of 14-DEC-2017 or lot # M019841 with expiration date of 20-APR-2018; dose and route of administration were not reported) that was reconstituted with the properly stored sterile diluent. No adverse effects and no previous temperature excursion were reported. Data logger was involved. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1704USA009837:
Patient reported her arm got really swollen and red, symptoms started the evening after she received the shot, and progressively got worse. Patient came back to pharmacy next day to seek help, RPH Evan suggested benadryl cream, which patient used and her arm got better after a day.
Pt reported red swollen rash, arthrus like bump at injection site & anxiety. Used inhaler x2 after getting vaccine.
24 hours post vax, pt. experienced fever, chills, abdominal pain, nausea, and malaise.
The patient was given a vaccine that expired 13 days ago, there has been no adverse event at this time.
This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administrated by other route in a 74-year-old male patient who received SHINGRIX. Concomitant products included digoxin, vitamin D, Warfarin, dofetilide and metoprolol. On 26th April 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On 26th April 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. Additional details were provided as follows: The concomitant product include multivitamin. The SHINGRIX was administered to the patient subcutaneously instead of intramuscularly, which led to inappropriate route of vaccine administration. The reporter gave permission to be contacted for further information. All questions were asked, reporter provided limited information. Follow up information was received by a pharmacist via call center representative on 30th May 2018: The patient's demographic details were updated. The patient may have been received SHINGRIX subcutaneously instead of intramuscular route. Less than a year after receiving SHINGRIX, the patient experienced injection site pain and arm swelling for about a week. The reporter's details and VAERS details were updated.
12/23/20 - RECEIVED 1ST DOSE OF COVID-19 VACCINE IN AM FROM EMPLOYEE HEALTH CLINIC 12/24/20 EVENING -  ACUTE ONSET OFSYMPTOMS HIGH FEVERS >101 - 103 F, SEVERE CONSTANT HEADACHES (PAIN SCALE AT 10), BODY ACHES, NAUSEA, FATIGUE, DIMISHED TASTE AND SMELL AND DIARRHEA SYMPTOMS CONTINUED TILL 1/7/2021 - SLOWLY IMPROVING
having a systemic reaction to her second dose received on 6/16/21 ? She is swollen head to toe and at the urgent treatment center
In 4/90, 11 days post vax, the pt experienced recurrent focal seizures. At the time his HIV infection was diagnosed in 10/85, blood analysis consistently revealed leukopenia, mild thrombocytopenia and hemoglobin concentrations of 11.2 to 13.6, lymphocyte counts were around 200-300, CD4 to CD8 ratios of 0.2-0.47. In 10/89, therapy with zidovudine was initiated. The pt had no symptoms related to HIV infection or zidovudine therapy. Although he had received the measles vaccine in 1973 at the age of 3 and a dose of MMR in 1976 at the age of 7, the pt was admitted to the hospital for three days in 2/90 with uncomplicated measles. Tachypnea and respiratory distress responded promptly to therapy with oxygen and aerosolized ribavirin. The pt responded well until two months later, when he presented after two days of recurrent right arm twitches without fever. Physical exam revealed only continuous fine twitches of th right arm. CSF analysis and computed tomography of the head gave normal results, electroencephalography, however, showed right frontal slowing with spike discharges centrally, persisted despite therapeutic anticonvulsant concentrations in serum. the pt was admitted 11 days after the onset of seizures for further diagnostic evaluation. At the time of admission, he was conscious and afebrile. He had right-arm and right-leg twitching but was able to walk. His mental status and the results of motor and sensory examination were normal. Although the latter condition responded to the fluid restriction, the pt developed slurred speech and gradually became unresponsive requiring endotracheal intubation. A 10 day course of IV therapy was given. The pt remained comatose, experiencing continuous focal seizures that could not be controlled with anticonvulsant agents. Neurological and electroencepahlographic exam on day 24 of hospitalization indicated brain death. Mechanical ventilation was discontinued on day 30. The cause of death was subacute measles encephalitis.
103 fever, uncontrollable shakes, migraine, throwing up, no apetite
PT HAS BEEN TREATED FOR BURSITIS BY A DOCTOR AND HAS HAD 2 ROUNDS OF STEROIDS.
Transverse Myelitis requiring IV solumedrol 1000 mg daily x 5 days then 32 mg oral BID  weaning by 4 mg daily until off (last dose 4/20/21) Hospitalized x 12 days including rehab being discharged with a walker and previously fully ambulatory 8 weeks physical therapy Off work x 7 weeks Continue to require muscle relaxer at HS Effect to right leg with tightness, numbness to right axilla and side, pain at T1 area to right anterior and posterior, gait effected , but  improving with no support Confirmed was not MS Treated for Guillain Barre post flu vaccine in 2013
Achiness, Congestion, which got prgressively worse to become food intolerance ...Hives, itchy throat & choking, anaphylatic reactions to food which increased with time!
Narrative:  Patient is a 57 year old male for whom his PCP documented that he had a reported ADR to the flu vaccine in 1987. He was working in another country, had a reaction of nausea and vomiting. He was hospitalized and has not had another flu shot since.
running a fever of 102.6; achy; This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (running a fever of 102.6) and MYALGIA (achy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (running a fever of 102.6) and MYALGIA (achy). At the time of the report, PYREXIA (running a fever of 102.6) and MYALGIA (achy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: high (High) fever of 102.6F.         No Concomitant Drug details were reported.  No Treatment information was provided.   This case was linked to MOD-2021-404967 (Patient Link).
Excessive menstrual bleeding. Cycle started on 5/4. Today is the 21st and I'm still bleeding. This is abnormal. I usually consistently bleed for 5 days or less.
Headache, Myalgia, Fever, pain at site both doses = other symptoms second dose only  Narrative:  Other Relevant History:
Approximately 3 minutes after receiving the above immunizations to left thigh patient developed a single urticarial wheal, approximately 4 cm, to left face adjacent to mouth and then a second approximately 1cm above right aspect of lip. She has received PROQUAD in past; this was first exposure to QUADRACEL. Previous DTaP/IPV immunizations were with PENTACEL.
3.5cm erythema, edema, hear  to Rt deltoid. Patient reports itching at site.
Within 2 hours severe headache last three days medication did not ease, since getting headaches off and on. (Took Tylenol)  Fever day 2 and 3 (Took Tylenol)  since get periods of hot flashes. Sore right arm from elbow to neckline for 7 days. After 7 days right arm area of  injection measuring approximately 6 inches by 6 inches swollen hot to touch rash looking mild itch, (Took Tylenol and Benadryl ) lasted 9 days. Today got checked by doctor area only pink not hot to touch,  blood pressure 172/92 do not have high blood pressure monitoring for two weeks will treat if does not go back to normal. Advised to wait for second shot which was scheduled for 21 September 2021 maybe at least a week later to report symptoms to this site.
Patients parent sent a picture of the patients arm 12 hours after it was given.  Arm was swollen from the injection site to the elbow and very red.  Pictures sent the following day after the vaccine showed noticeable improvement in the redness and swelling. Patients mother denies any fever or respiratory symptoms
Patient presented 2/17 with left side bells palsey, left sided facial droop, facial paresthesia and diffuse headache. No acute findings on CT or MRI. Patient discharge 2/18. , hospitalizations are to be reported irrespective of attribution to the vaccine
Two days after, I had flu like symptoms, chills, fever, that lasted probably 12 hours or something like that. Then my conditions improved. I was able to go to work for two days. Then at work, I started getting really dizzy all of a sudden. I needed someone to cover for me, and I couldn't safely stand, and I vomited and saw some blood. The nurse at work took my BP and it was 160/120. Someone took me home and I had vertigo and tinnitus. I had to vomit again, and there was more blood. I called the paramedics, and they took me to the hospital. And I was there for two days. They did an endoscopy and found nothing in the esophagus or stomach. I was discharged but I still had vertigo. So, they gave me medicine for the dizziness and vomiting. I still had the tinnitus for the month, and then ever since, everything has been fine.